白血病和淋巴瘤中的CDK抑制剂

{"title":"白血病和淋巴瘤中的CDK抑制剂","authors":"Yun Dai, S. Grant","doi":"10.1201/9780429114670-15","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":215422,"journal":{"name":"Innovative Leukemia and Lymphoma Therapy","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CDK Inhibitors in Leukemia and Lymphoma\",\"authors\":\"Yun Dai, S. Grant\",\"doi\":\"10.1201/9780429114670-15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":215422,\"journal\":{\"name\":\"Innovative Leukemia and Lymphoma Therapy\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovative Leukemia and Lymphoma Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/9780429114670-15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovative Leukemia and Lymphoma Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/9780429114670-15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}